{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "exchange": "NCM", "regularMarketChangePercent": 1.9969221, "regularMarketPrice": 3.32, "firstTradeDateMilliseconds": 1617629400000, "priceHint": 4, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.35, "epsForward": -0.47, "epsCurrentYear": -0.34, "priceEpsCurrentYear": -9.764706, "sharesOutstanding": 126507000, "bookValue": 1.438, "fiftyDayAverage": 3.2229, "fiftyDayAverageChange": 0.09710002, "fiftyDayAverageChangePercent": 0.030128153, "twoHundredDayAverage": 3.570775, "twoHundredDayAverageChange": -0.2507751, "twoHundredDayAverageChangePercent": -0.07022988, "marketCap": 434843616, "forwardPE": -7.06383, "priceToBook": 2.308762, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-02", "averageAnalystRating": "1.6 - Buy", "tradeable": false, "cryptoTradeable": false, "shortName": "Compass Therapeutics, Inc.", "longName": "Compass Therapeutics, Inc.", "messageBoardId": "finmb_266166780", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.06499982, "regularMarketTime": 1684180804, "regularMarketDayHigh": 3.35, "regularMarketDayRange": "3.28 - 3.35", "regularMarketDayLow": 3.28, "regularMarketVolume": 174809, "regularMarketPreviousClose": 3.255, "bid": 0.0, "ask": 0.0, "bidSize": 9, "askSize": 8, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 3.31, "averageDailyVolume3Month": 346815, "averageDailyVolume10Day": 253870, "fiftyTwoWeekLowChange": 1.51, "fiftyTwoWeekLowChangePercent": 0.83425415, "fiftyTwoWeekRange": "1.81 - 5.65", "fiftyTwoWeekHighChange": -2.3300002, "fiftyTwoWeekHighChangePercent": -0.4123894, "fiftyTwoWeekLow": 1.81, "fiftyTwoWeekHigh": 5.65, "displayName": "Compass Therapeutics", "symbol": "CMPX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "80 Guest Street", "address2": "Suite 601", "city": "Boston", "state": "MA", "zip": "02135", "country": "United States", "phone": "617 500 8099", "website": "https://www.compasstherapeutics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. Compass Therapeutics, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 26, "companyOfficers": [{"maxAge": 1, "name": "Dr. Thomas J. Schuetz M.D., Ph.D.", "age": 61, "title": "Co-Founder, CEO & Director", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 829557, "fmt": "829.56k", "longFmt": "829,557"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 376735, "fmt": "376.74k", "longFmt": "376,735"}}, {"maxAge": 1, "name": "Dr. Vered  Bisker-Leib M.D., MBA, Ph.D.", "age": 50, "title": "Pres & COO", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 806433, "fmt": "806.43k", "longFmt": "806,433"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 269821, "fmt": "269.82k", "longFmt": "269,821"}}, {"maxAge": 1, "name": "Mr. Neil L. Lerner CPA", "age": 55, "title": "VP of Fin.", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jonathan  Anderman J.D.", "title": "VP, Head of Legal & Corp. Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Anna  Gifford", "title": "Communications Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peter F. Moesta Ph.D.", "title": "Interim Head of CMC", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}